X4 Pharmaceuticals is committed to upholding the highest standards of integrity and ethics in everything we do. Our Compliance and Ethics Program (the “Program”) is designed pursuant to guidance issued by Office of Inspector General of the Department of Health and Human Services (OIG), in support of our mission to develop and commercialize innovative therapies for those with rare diseases and significant unmet needs. We expect every X4 employee to share in our commitment to integrity and put the patient at the center of everything we do.
The elements of our Program are outlined in X4 Pharmaceuticals’ Code of Business Conduct and Ethics. This and other related documents can be found below:
Price Transparency Disclosures: